|
UNC13B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.619500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.420810E-03 |
| Normal-vs-Stage2 |
3.436100E-02 |
| Normal-vs-Stage3 |
1.563740E-04 |
| Normal-vs-Stage4 |
1.39319999981069E-09 |
| Stage1-vs-Stage2 |
7.561600E-01 |
| Stage1-vs-Stage3 |
3.153500E-02 |
| Stage1-vs-Stage4 |
5.53529999999247E-05 |
| Stage2-vs-Stage3 |
1.775750E-01 |
| Stage2-vs-Stage4 |
7.236300E-03 |
| Stage3-vs-Stage4 |
5.321900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.463400E-03 |
| Normal-vs-AfricanAmerican |
7.394200E-04 |
| Normal-vs-Asian |
4.44050000003582E-06 |
| Caucasian-vs-AfricanAmerican |
4.808800E-01 |
| Caucasian-vs-Asian |
1.332190E-02 |
| AfricanAmerican-vs-Asian |
8.380200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.778800E-03 |
| Normal-vs-Female |
7.960100E-03 |
| Male-vs-Female |
6.908400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.96299999999372E-06 |
| Normal-vs-Extreme_Weight |
3.97419999997872E-06 |
| Normal-vs-Obese |
2.857400E-03 |
| Normal-vs-Extreme_Obese |
7.903200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.567000E-01 |
| Normal_Weight-vs-Obese |
1.634760E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.800400E-03 |
| Extreme_Weight-vs-Obese |
4.482000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.249580E-02 |
| Obese-vs-Extreme_Obese |
9.525500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.940700E-03 |
| Normal-vs-Age(41-60Yrs) |
3.595700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.405570E-02 |
| Normal-vs-Age(81-100Yrs) |
1.201850E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.905010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.913160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.790200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.440400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.581800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.465800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.412400E-02 |
| Normal-VS-Type2 PRCC |
1.075600E-02 |
| Normal-VS-KIRP CIMP |
1.82940329551684E-11 |
| Normal-VS-Unclassified PRCC |
5.507500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.104800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.84420265117546E-11 |
| Type1 PRCC-VS-Unclassified PRCC |
5.008200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.44110000494169E-08 |
| Type2 PRCC-VS-Unclassified PRCC |
8.171200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.811100000086E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.904670E-03 |
| Normal-vs-N1 |
2.193800E-01 |
| Normal-vs-N2 |
1.298980E-03 |
| N0-vs-N1 |
7.222400E-01 |
| N0-vs-N2 |
4.351600E-01 |
| N1-vs-N2 |
7.857400E-01 |
|
|
